You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Breast Cancer Trial in Beijing (Modified radical mastectomy for breast cancer, neoadjuvant therapy, Systematic

Recruiting
  • Locally Advanced Breast Cancer
  • Modified radical mastectomy for breast cancer
  • +2 more
  • Beijing, China
    Ying Xu
Oct 6, 2023

Sentinel Lymph Node, Breast Cancer, Locally Advanced Trial in Hospitalet de Llobregat, Barcelona (Target Axillary Dissection)

Recruiting
  • Sentinel Lymph Node
  • +2 more
  • Target Axillary Dissection
  • Hospitalet de Llobregat, Barcelona, Spain
  • +1 more
Mar 11, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Pre-analytical Factors Affecting ctDNA Analysis in Early and

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jul 6, 2023

Breast Cancer, Neoadjuvant Therapy Trial in Beijing (Utidelone, Carboplatin, Epirubicin)

Not yet recruiting
  • Breast Cancer
  • Neoadjuvant Therapy
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Aug 1, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Breast Tumors Trial in Shanghai (Neoadjuvant radiotherapy)

Recruiting
  • Breast Neoplasms
  • Neoadjuvant radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 28, 2022

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Breast Cancer, Locally Advanced Breast Cancer Trial in United States (Sentinel Lymph Node Biopsy (SLNB))

Recruiting
  • Breast Cancer
  • Locally Advanced Breast Cancer
  • Sentinel Lymph Node Biopsy (SLNB)
  • Miami, Florida
  • +7 more
Nov 7, 2022

Breast Cancer Trial in Chengdu (Pyrotinib combined with albumin-bound paclitaxel and trastuzumab)

Recruiting
  • Breast Cancer
  • Pyrotinib combined with albumin-bound paclitaxel and trastuzumab
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Oct 7, 2022

Breast Cancer Trial (HRS-1358)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Nov 17, 2022

HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Eribulin mesylate injection、Pertuzumab、Trastuzumab
  • Guanzhou, Guangdong, China
    LI YuDong
Jul 13, 2023

Breast Cancer, Neoadjuvant Trial in Wuhan (pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel)

Recruiting
  • Breast Cancer
  • Neoadjuvant
  • pyrotinib,Trastuzumab，carboplatin，Albumin paclitaxel
  • Wuhan, Hubei, China
  • +1 more
Aug 18, 2023

Early-stage Breast Cancer, Locally Advanced Breast Cancer Trial in Singapore (Exercise Programme, Control)

Recruiting
  • Early-stage Breast Cancer
  • Locally Advanced Breast Cancer
  • Exercise Programme
  • Control
  • Singapore, Singapore
  • +2 more
Jul 19, 2023

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Breast Cancer Trial in Chengdu (Disitamab Vedotin, Penpulimab)

Not yet recruiting
  • Breast Cancer
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Feb 9, 2023

Breast Cancer, Metastatic Breast Cancer Trial in Caen, Rouen (Blood sampling)

Recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Blood sampling
  • Caen, France
  • +1 more
May 27, 2022

Human Epidermal Growth Factor Receptor 2-Positive Unresectable

Active, not recruiting
  • Metastatic Breast Cancer
  • Locally Advanced Breast Cancer
    • Athens, Greece
    • +1 more
    Jun 20, 2022

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    Local Cancer Trial in Roma, Rome (Prognostic model)

    Recruiting
    • Local Cancer
    • Prognostic model
    • Roma, Italy
    • +2 more
    Mar 28, 2023

    Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • HER2-positive Breast Cancer
    • exosome and ctDNA evaluation
    • Seoul, Korea, Republic of
      Ji-Yeon Kim
    Jul 13, 2023

    HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

    Active, not recruiting
    • HER2-positive Breast Cancer
    • TQB2440 injection + Trastuzumab + Docetaxel
    • Perjeta + Trastuzumab + Docetaxel
    • Chongqing, Chongqing, China
    • +5 more
    Aug 3, 2023

    Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)

    Recruiting
    • Locally Advanced Breast Cancer
    • Hormone Receptor Positive，HER2-negative Breast Cancer
    • Jinan, Shandong, China
      Breast Cancer Center, Shandong Cancer Hospital and Institute
    Apr 11, 2023

    Breast Cancer Trial (Intuzumab, pyrrolidone, nab-paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • Intuzumab, pyrrolidone, nab-paclitaxel
    • (no location specified)
    Jun 29, 2022